The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA

FEMS Microbiology Letters
Stephen C BeckerDavid M Donovan

Abstract

LysK is the endolysin from the staphylococcal bacteriophage K, and can digest the cell wall of many staphylococci. Lysostaphin is a bacteriocin secreted by Staphylococcus simulans to kill Staphylococcus aureus. Both LysK and lysostaphin have been shown to lyse methicillin-resistant S. aureus (MRSA). This study describes optimal reaction conditions for the recombinant His-tagged LysK protein (pH range pH 6-10, and 0.3-0.5 M NaCl), and C-His-LysK MIC (32.85+/-4.87 mug mL(-1)). LysK and lysostaphin demonstrate antimicrobial synergy by the checkerboard assay.

References

May 1, 1983·The Journal of Antimicrobial Chemotherapy·M J HallD Westmacott
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·G CisaniO Soro
Oct 12, 2000·American Journal of Ophthalmology·J J DajcsR J O'Callaghan
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D NelsonV A Fischetti
May 23, 2002·Antimicrobial Agents and Chemotherapy·Nandini KiriMichael W Climo
Aug 23, 2002·Nature·Raymond SchuchVincent A Fischetti
May 3, 2003·Annals of the New York Academy of Sciences·Vincent A Fischetti
Feb 15, 1965·Biochimica Et Biophysica Acta·C A SCHINDLER, V T SCHUHARDT
Apr 23, 1965·Biochemical and Biophysical Research Communications·H P BROWDERP A TAVORMINA
Oct 24, 2003·Infection and Immunity·Jutta M LoefflerVincent A Fischetti
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Julie A WuJohn F Kokai-Kun
Nov 14, 2003·The Journal of Antimicrobial Chemotherapy·Isabel JadoUNKNOWN Spanish Pneumococcal Infection Study Network
Mar 27, 2004·Protein Science : a Publication of the Protein Society·Matthias BochtlerIzabela Sabala
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Qi ChengVincent A Fischetti
Jun 28, 2005·Current Opinion in Microbiology·Martin J Loessner
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Caroline M Kusuma, John F Kokai-Kun
Aug 30, 2005·Trends in Microbiology·Vincent A Fischetti
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·J M EntenzaP Moreillon
Apr 7, 2006·Applied and Environmental Microbiology·David M DonovanDavid G Pritchard
Jan 1, 2007·Recent Patents on Biotechnology·David M Donovan

❮ Previous
Next ❯

Citations

Oct 19, 2012·Applied Microbiology and Biotechnology·Piotr SzwedaSlawomir Milewski
Feb 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A P Desbois, P J Coote
Mar 22, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sofia FernandesCarlos São-José
Apr 6, 2013·The Journal of Antimicrobial Chemotherapy·Yang ShenDaniel C Nelson
Jan 26, 2011·Antimicrobial Agents and Chemotherapy·Soo Youn JunSang Hyeon Kang
Nov 5, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jan BorysowskiAndrzej Górski
Oct 4, 2012·Future Microbiology·Mathias SchmelcherMartin J Loessner
May 30, 2014·The Journal of Antimicrobial Chemotherapy·Tania Mareike ViertelHans-Peter Horz
May 24, 2015·Enzyme and Microbial Technology·Lyubov Y FilatovaAlexander V Kabanov
Dec 29, 2015·Current Opinion in Biotechnology·Maxwell L Van TassellMichael J Miller
Jun 12, 2010·International Journal of Food Microbiology·Pilar GarcíaAna Rodríguez
Aug 5, 2011·Journal of Applied Microbiology·M FentonA Coffey
Apr 22, 2015·Applied Microbiology and Biotechnology·Mathias SchmelcherDavid M Donovan
Jan 2, 2013·International Journal of Antimicrobial Agents·Soo Youn JunSang Hyeon Kang
Feb 18, 2011·Bioengineered Bugs·Mark FentonAidan Coffey
Feb 27, 2015·Frontiers in Cellular and Infection Microbiology·Tomas FiedlerBernd Kreikemeyer
Nov 21, 2013·The Analyst·Hicham ChibliJay L Nadeau
Dec 31, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Gil YeroslavskyShai Rahimipour
Jun 6, 2009·FEMS Microbiology Letters·Stephen C BeckerDavid M Donovan
Apr 29, 2016·Scientific Reports·Stephen C BeckerDavid M Donovan
Oct 19, 2016·Current Opinion in Microbiology·Michael Wittekind, Raymond Schuch
Dec 10, 2013·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Marta Sanz-GaiteroMark J van Raaij
Oct 25, 2016·International Journal of Antimicrobial Agents·Varish AhmadMughees Uddin Siddiqui
Feb 6, 2017·Applied and Environmental Microbiology·Carolin T VerbreeMathias Schmelcher
May 4, 2017·Antimicrobial Agents and Chemotherapy·Raymond SchuchMichael Wittekind
Jul 26, 2017·Science Progress·Jude AjueborAidan Coffey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.